Robert W. Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert W. Gao has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
David M. Routman
Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
3 shared publicationsDaniel J. Ma
Department of Radiation Oncology Mayo Clinic Rochester Minnesota USA
2 shared publicationsLisa A. McGee
Department of Radiation Oncology Mayo Clinic Scottsdale Arizona USA
2 shared publicationsRobert L. Foote
Department of Radiation Oncology Mayo Clinic Rochester Minnesota USA
2 shared publications- Robert W. Mutter
Department of Radiation Oncology, Mayo Clinic, Rochester, USA
2 shared publications Samir H. Patel
Department of Radiation Oncology Mayo Clinic Scottsdale Arizona USA
2 shared publications
Latest Publications
- Open Access
- 25 May 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 117 (4) , 846-856
Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes
- 25 May 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 117 (4) , 846-856
Open AccessPostmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes
- 12 October 2022
- Published by Wiley in Head & Neck
- Vol. 45 (1) , 187-196
Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity‐modulated radiotherapy
Background: We seek to inform radiotherapy (RT) delivery for adenoid cystic carcinoma of the head and neck (ACC) by evaluating RT techniques and recurrence patterns.Methods: We identified patients with ACC treated with curative‐intent RT from 2005 to 2021. Imaging was reviewed to determine local recurrence (LR).Results: Ninety‐one patients were included. The 5‐year LR risk was 12.2% (6.6–22.7). One patient each experienced a marginal and out‐of‐field recurrence. Patients receiving >60 Gy postoperatively had a 5‐year LR risk of 0% compared to 10.7% (4.2–27.2) with ≤60 Gy. Those receiving 70 and 60 and 70 Gy may improve control in the postoperative and definitive settings, respectively. Elective nodal treatment can be omitted in well‐selected patients.
- 12 October 2022
- Published by Wiley in Head & Neck
- Vol. 45 (1) , 187-196
Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity‐modulated radiotherapy
Background: We seek to inform radiotherapy (RT) delivery for adenoid cystic carcinoma of the head and neck (ACC) by evaluating RT techniques and recurrence patterns.Methods: We identified patients with ACC treated with curative‐intent RT from 2005 to 2021. Imaging was reviewed to determine local recurrence (LR).Results: Ninety‐one patients were included. The 5‐year LR risk was 12.2% (6.6–22.7). One patient each experienced a marginal and out‐of‐field recurrence. Patients receiving >60 Gy postoperatively had a 5‐year LR risk of 0% compared to 10.7% (4.2–27.2) with ≤60 Gy. Those receiving 70 and 60 and 70 Gy may improve control in the postoperative and definitive settings, respectively. Elective nodal treatment can be omitted in well‐selected patients.
- 13 June 2022
- Published by Elsevier in Lung Cancer
- Vol. 170, 58-64
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
- 13 June 2022
- Published by Elsevier in Lung Cancer
- Vol. 170, 58-64
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
- 1 March 2022
- Published by Elsevier in Practical Radiation Oncology
- Vol. 12 (2) , 113-119
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy
- 1 March 2022
- Published by Elsevier in Practical Radiation Oncology
- Vol. 12 (2) , 113-119
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy
- 1 June 2021
- Published by Elsevier in European Urology Oncology
- Vol. 4 (3) , 447-455
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
- 1 June 2021
- Published by Elsevier in European Urology Oncology
- Vol. 4 (3) , 447-455
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer
- 1 November 2018
- Published by Elsevier in Practical Radiation Oncology
- Vol. 8 (6) , 361-365
Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient
- 1 November 2018
- Published by Elsevier in Practical Radiation Oncology
- Vol. 8 (6) , 361-365
Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient